Zevra Therapeutics (ZVRA) Other Non-Current Liabilities (2014 - 2026)
Zevra Therapeutics' Other Non-Current Liabilities was $13.17 million in Q2 2026, down 24.7% from $17.48 million a year earlier but up 91.6% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends
At the end of FY2025, Other Non-Current Liabilities at Zevra Therapeutics came in at $9.58 million, down 46.2% from FY2024.
- Other Non-Current Liabilities shows a five-year compound annual growth rate of 99.4% (FY2020 to FY2025).
- In earlier years, Other Non-Current Liabilities was $17.8 million in FY2024 (+10.6%), $16.1 million in FY2023 (+57.8%), $10.2 million in FY2022 and $330,000 in FY2021 (+8.6%).
- Quarterly Other Non-Current Liabilities has moved between $35,000 (Q3 2022) and $17.8 million (Q4 2024) over five years.
- Compared with a year earlier, Other Non-Current Liabilities has declined for three straight quarters, with growth averaging 9.9% over the last seven quarters.
- The best year-over-year quarter for Other Non-Current Liabilities over five years was Q2 2023 (growth of 456.1%); the worst was Q2 2022 (a decline of 92.2%).
- Per Business Quant data, ZVRA's Other Non-Current Liabilities in the three quarters before Q2 2026 was $6.87 million (Q1 2026), $9.58 million (Q4 2025) and $17.46 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Zevra Therapeutics | 650.98 Mn | -161.73 Mn | 38.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.17 Mn |
| Mar 31, 2026 | 6.87 Mn |
| Dec 31, 2025 | 9.58 Mn |
| Sep 30, 2025 | 17.46 Mn |
| Jun 30, 2025 | 17.48 Mn |
| Mar 31, 2025 | 16.17 Mn |
| Dec 31, 2024 | 17.80 Mn |
| Sep 30, 2024 | 13.90 Mn |
| Jun 30, 2024 | 7.90 Mn |
| Mar 31, 2024 | 11.54 Mn |
| Dec 31, 2023 | 16.10 Mn |
| Sep 30, 2023 | 420,000.00 |
| Jun 30, 2023 | 317,000.00 |
| Mar 31, 2023 | 158,000.00 |
| Dec 31, 2022 | 10.20 Mn |
| Sep 30, 2022 | 35,000.00 |
| Jun 30, 2022 | 57,000.00 |
| Mar 31, 2022 | 89,000.00 |
| Dec 31, 2021 | 330,000.00 |
| Sep 30, 2021 | 396,000.00 |
API Access
Zevra Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();